Back
PTC Therapeutics Vs. Catalyst Pharmaceuticals Industry Stock Comparison
Buy
64
PTCT
PTC Therapeutics
Last Price:
32.30
Seasonality Move:
20.4%
Buy
55
CPRX
Catalyst Pharmaceuticals
Last Price:
15.94
Seasonality Move:
16.36%
Buy
64
PTC Therapeutics (PTCT)
is a Buy
Is PTC Therapeutics a Buy, Sell or Hold?
- The current PTC Therapeutics [PTCT] share price is $32.25. The Score for PTCT is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- PTCT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
55
Catalyst Pharmaceuticals (CPRX)
is a Buy
Is Catalyst Pharmaceuticals a Buy, Sell or Hold?
- The current Catalyst Pharmaceuticals [CPRX] share price is $15.94. The Score for CPRX is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- CPRX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PTCT Stock Price Chart
What is PTC Therapeutics's stock price today?
-
The PTC Therapeutics share price today is $32.25
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTCT is experiencing slight buying pressure.
CPRX Stock Price Chart
What is Catalyst Pharmaceuticals's stock price today?
-
The Catalyst Pharmaceuticals share price today is $15.94
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CPRX is experiencing slight selling pressure.
PTCT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.26 | Buy |
Relative Strength Index (14 RSI): | 61.44 | Buy |
Chaikin Money Flow: | 281278 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (25.4 - 31.9) | Buy |
Bollinger Bands (100): | (25.94 - 30.42) | Buy |
CPRX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.04 | Sell |
Relative Strength Index (14 RSI): | 57.69 | Buy |
Chaikin Money Flow: | -38307 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.87 - 15.67) | Buy |
Bollinger Bands (100): | (14.19 - 16.25) | Buy |
PTCT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 32.5 | Sell |
20-day SMA: | 29.06 | Buy |
50-day SMA: | 29.19 | Buy |
200-day SMA: | 28.34 | Buy |
8-day EMA: | 31.6 | Buy |
20-day EMA: | 30.22 | Buy |
50-day EMA: | 28.99 | Buy |
200-day EMA: | 30.25 | Buy |
CPRX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 15.17 | Buy |
20-day SMA: | 15.18 | Buy |
50-day SMA: | 15.68 | Buy |
200-day SMA: | 14.3 | Buy |
8-day EMA: | 15.3 | Buy |
20-day EMA: | 15.25 | Buy |
50-day EMA: | 15.28 | Buy |
200-day EMA: | 14.64 | Buy |
PTC Therapeutics Earnings Growth & PTCT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.47 per share, an increase next quarter of $0.44 per share, a decrease this year of $0.61 per share, and an increase next year of $1.56 per share.
Catalyst Pharmaceuticals Earnings Growth & CPRX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.10 per share, a decrease this year of $0.18 per share, and an increase next year of $0.41 per share.
PTC Therapeutics Technical Analysis
Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Catalyst Pharmaceuticals Technical Analysis
Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |